Drying of Opzelura® (Ruxolitinib) Cream 1.5%: Implications for Clinical and Real-World Use. J of Skin [Internet]. 2024 Nov. 18 [cited 2026 May 26];8(6):s454. Available from: https://skin.dermsquared.com/skin/article/view/3063